Deformation of brains in patients phenocopies murine findings.
The solid stress-mediated deformation of the surrounding tissue observed in preclinical models may reflect the 'mass effect' macroscopically observed in radiological exams in brain tumour (that is, tumour-induced deformation of the brain). We therefore investigated the deformation of the brain anatomy in patients. MRI allowed us to longitudinally observe the tumour growth in patients with GBM. Initial evidence in a post-surgery cohort suggested that nodular tumours had a larger mass effect than infiltrative ones (Supplementary Fig. 2a and Supplementary Videos 2 and 3). To investigate the association between the mass effect and neurologic deficit, we correlated brain tumour growth patterns with pre-surgery Karnofsky performance scores (KPSs), a clinical index used to estimate functional impairment. We used contrast-enhanced (CE)-T1-weighted, T2-weighted and FLAIR images from MRI as well as the Visually Accessible Rembrandt Images (VASARI) criteria for characterization of tumour margins 10 . This allowed us to stratify a cohort of 64 pre-surgery, pre-treatment GBM patients using a scoring method for the definition of enhancing and non-enhancing margins (Fig. 1e ). We discovered that patients with perfectly defined margins of the tumour (that is, nodular, 29.7% in our cohort) showed a lower pre-surgery KPS than patients with ill-defined margins (Fig. 1f ). Stratification based on CE-T1 or T2-and FLAIR showed comparable results ( Supplementary Fig. 2b) . Importantly, the nodular and infiltrative cohorts did not differ in tumour (CE-T1) or edema (T2-and FLAIR) volume ( Supplementary Fig. 2c ), suggesting that the association between tumour growth pattern and KPS is independent from the well-known effect of peritumour edema. The significant difference in pre-operative KPS between nodular (median KPS = 80) and infiltrative tumours (median KPS = 90) was especially provocative, in light of previously reported differences between KPS measured pre-and post-surgical resection of the tumour, where we expect a complete removal of the solid stress caused by the tumour 11 .
These findings from mouse models and humans (measurements of solid stress, deformation of the surrounding brain and the resulting functional impairments) suggest that nodular brain tumourscompared with those that are more infiltrative-exert significant chronic local compression and tension on the surrounding brain tissue and this may affect neurological function.
Nodular brain tumours impair vascular perfusion of adjacent normal tissue and neuronal function.
To shed light on the consequences of the local tumour-generated solid stresses on the surrounding brain and to investigate the mechanopathological basis for the performance reduction in patients with nodular tumours, we assessed vascular perfusion in mice bearing GBM and BC brain metastasis. We previously demonstrated that solid stress compresses blood vessels within tumours 3, 6, 12 and predicted this in non-central nervous system (non-CNS) tissues 7 . Using Doppler optical coherence tomography (OCT 13 ), we performed longitudinal high-resolution angiography in tumour-bearing live mice with transparent cranial windows. We observed that nodular brain tumours-U87 (GBM), GL261 (mouse GBM) and BT474 (BC) ( Supplementary  Fig. 1a )-gradually displaced the surrounding vascular architecture and impaired vascular perfusion by reducing vascular volume fraction and vessel diameters ( Fig. 2a,b, Supplementary Fig. 3 and Supplementary Videos 4 and 5). Moreover, we observed that the reduction in perfusion in the brain tissue strongly correlated with the tumour volume in nodular models ( Supplementary Fig. 4a ). Notably, the infiltrative MGG8 GBMs did not cause vascular perfusion reduction in the surrounding brain tissue ( Fig. 2b and Supplementary Fig. 3a) .
To investigate the effect of mechanical stress on normal brain tissue at the cellular level, we imaged blood flow and tumour cells intravitally and longitudinally using multiphoton microscopy. We observed that the nodular GL261 tumours deformed vessels and reduced the vascular area fraction and vessel diameters in the observed region at the border of the tumour, while the infiltrative MGG8 cells penetrated into the brain tissue without perturbing vascular architecture and vessel perfusion ( Fig. 2c) .
We then investigated the effects of mechanical stress on neurons in the surrounding brain tissue. Using intravital multiphoton microscopy, we imaged enhanced green fluorescent protein (EGFP)-H2B mice (which have GFP-positive nuclei) bearing Discosoma red fluorescent protein (DsRed)-GL261 tumours. Nuclei within the surrounding tissue were locally deformed (Fig. 3a) , a potential consequence of compressive force. Solid stress compresses the cells, which transmit the compressive force to the nucleus, resulting in deformed nuclei. Since the intravital imaging Articles NaTure BiOmedical eNgiNeeriNg of our reporter mouse model was not able to distinguish between neurons and the rest of the brain stromal cells, we performed immunohistochemistry (IHC) to stain the neuronal nuclei around nodular tumours. We observed the same nuclear deformation and a gradient of nuclear area reduction in neurons in the tissue surrounding the nodular tumours (Fig. 3b,c and Supplementary   Fig. 4b,c) . Notably, no deformation or area reduction was detected in neuronal nuclei around infiltrative MGG8 tumours (Fig. 3b,c and Supplementary Fig. 4b,c ). Compression of neurons has been shown to cause neural cell death in vitro 14, 15 . Similarly, we detected signs of apoptosis in the tissue surrounding nodular tumours ( Fig. 3d and Supplementary Fig. 4d ). nodular tumours mechanically affect the surrounding brain. a-c, Solid stress in mouse models of nodular (patient-derived U87 cell line) and infiltrative brain tumours (patient-derived MGG8 cell line) in nude mice. a, High-resolution ultrasound imaging of the stress-induced deformation and representative stress profiles across the tumour diameter and the normal surrounding tissue. Scale bars, 1 mm. b,c, Estimation of the circumferential (compression; σ θθ ) and radial (tension; σ rr ) stress in the surrounding tissue obtained from mathematical modelling (described in Supplementary Fig. 1b-d and Methods). The data are the mean of three independent tumours ± s.e.m. Tum, tumour. d, Micro-anatomic deformation of the brain tissue around nodular tumours. IHC of U87 and MGG8 tumours at the interface of the normal brain tissue (neurons, NeuN staining; vessels, collagen IV staining). The arrows indicate the deformed region around the tumour; neurons are packed and vessels are displaced following the circumference of the tumour margin. T, tumour; B, brain. Representative images from a cohort of ten mice with a tumour are shown. Scale bars, 50 μ m. e, Representative T2-weighted (T2W) and FLAIR MRI of pre-surgery pre-treatment patients with GBM with perfectly defined (nodular) and ill-defined (infiltrative) margins. f, KPS histograms of patients with perfectly defined margins (nodular) or ill-defined GBM (infiltrative). The results are from a cohort of 64 pre-surgery pre-treatment GBM patients.
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Collectively, these results indicate that nodular tumours-in comparison to infiltrative ones-locally reduce perfusion by compressing blood vessels in the surrounding brain tissue as well as by compressing neuronal nuclei and inducing neuronal loss.
GBM and BC patients with nodular tumours present reduced vascular perfusion in the surrounding brain tissue and neurologic dysfunction.
To test whether our preclinical results on perfusion recapitulate those in patients, we investigated vascular perfusion in the surrounding normal-appearing tissues in a cohort of 64 presurgery GBM patients using MRI images. We assessed perfusion in the normal-appearing tissue, avoiding the regions of T2-weighted and FLAIR peritumoural edema and then normalizing with the whole-brain perfusion levels (which are different in each individual; Supplementary Fig. 5a ). Our analysis showed that 53% of patients experienced a local gradient of reduced perfusion in the surrounding brain tissue (Fig. 4a,b ). We also confirmed these perfusion results in an additional independent cohort of 14 post-surgery, but otherwise untreated, GBM patients ( Supplementary Fig. 5b -e).
The above imaging method allowed us to stratify the patients from our pre-surgery cohort on the basis of their level of perfusion in the surrounding tissue (that is, 'reduced perf ' or 'unchanged perf '). Patients with reduced perfusion in the surrounding tissue had significantly poorer KPS ( Fig. 4c ). Notably, these two patient cohorts showed similar levels of tumour volume and edema ( Fig. 4d ) and had equal pre-treatment with steroids ( Supplementary  Fig. 6a ). Moreover, diffusion tensor imaging MRIs displayed local deformation of the white matter anatomy in the surrounding brain tissue (Fig. 4b ), as previously shown 16 . We observed that the tumours with local reduction of perfusion ('reduced perf ') were more often classified as nodular ( Fig. 4e and Supplementary  Fig. 6b ), but no difference in the tumour shape was detected ( Supplementary Fig. 6c,d) .
As metastases in the brain are reported to be primarily nodular 17 , we then analysed a cohort of 34 patients with BC metastases in the brain with the same imaging approach as described above. Indeed, we observed markedly reduced perfusion in the surrounding tissue in proximity to the tumour (Fig. 4f,g and Supplementary Fig. 6e ). These results indicate that both primary and metastatic nodular tumours locally reduce vascular perfusion in the surrounding brain tissue and that this is correlated with neurological impairment. Supplementary Fig. 3b ,d. White dashed lines indicate the original position of the sagittal sinus, while the green line delimits the GL261 nodular tumour. Scale bar, 1 mm. b, Longitudinal quantitative analysis of the vascular perfused volume fraction in the surrounding tissue. GBM U87: day 17 *P = 0.025 versus the red-dotted time point (day 13); day 18 *P = 0.011; day 19 *P = 0.045; day 20 *P = 0.037. BC BT474: day 14 **P = 0.001 versus the red-dotted time point (day 5); day 18 *P = 0.024; day 21 **P = 0.003; day 25 **P = 0.005; day 28 **P = 0.001; day 32 ***P < 0.001; day 38 *P = 0.035. NS, not significant. The data are mean ± s.e.m. c, Intravital longitudinal multiphoton imaging depicting changes in vessel diameter in the nodular Gl261-GFP and in the infiltrative MGG8-GFP GBM mouse models. GFP (green, tumour cells) and TAMRA-dextran (red, 2 MDa dextran, blood flow). VA, vascular area. Scale bars, 20 μ m.
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In vivo solid stress application impairs vascular perfusion and induces neuronal dysfunction. Taken together, the above results in preclinical and clinical settings demonstrate a strong association between the gradient of solid stress and the reduction in local vessel and neural function in the surrounding brain tissue. To mechanistically confirm this link and distinguish the mechanical effects from biological interactions between the tumour and normal brain tissue (for example, cytokines and inflammation associated with cancer cells that are cytotoxic to normal cells 18 ), we directly and chronically applied mechanical compression to the brains in living mice with no tumour. This also avoided the confounding effect of the peritumoural edema. Our custom-designed in vivo apparatus was composed of a set screw mounted on a modified cranial window and separated from the brain tissue by a biocompatible and deformable membrane. By turning the screw into the cranial window in nude mice without tumour, we can control the displacement of brain tissue so that it resembles that caused by nodular tumours ( Fig. 5a and Supplementary Fig. 7a ). We expanded the compressing volume at around 1.3 mm 3 d −1 for 14 days and reached a maximum volume of approximately 19.0 ± 0.7 mm 3 . The rate of compression was comparable to the rate of growth in the nodular U87 and BT474 intracranial models over the same time period, while the maximum volume was less than the tumours at the end point ( Supplementary  Fig. 7b ). This method gradually and chronically compressed the brain and deformed the micro-anatomy of the cortex ( Fig. 5b and Supplementary Fig. 7c ) mimicking the effects of a nodular tumour ( Fig. 1d ). We then performed longitudinal angiography on mice with controlled and gradual compression on the brain and discovered that vascular perfusion and vessel diameter were reduced ( Fig. 5c and Supplementary Fig. 7d ), confirming our observation in nodular tumour-bearing brains ( Fig. 2a,b ).
Next, we investigated the effects of compressive stresses on neurons and other cellular components in the brain. First, ultrastructure analysis revealed signs of cell distress (condensed chromatin) in the compressed cortices ( Fig. 5d and Supplementary Fig. 7e ). In addition, we discovered that the NeuN-positive neuronal nuclear area was significantly reduced and deformed. The total number, area and circularity of neuronal nuclei were substantially reduced in the cortex after chronic compression ( Fig. 5e-g and Supplementary  Fig. 8a ). In the compressed cortices we also detected apoptosis, signs of degenerative autophagy (LC3-II-positive vesicles), reduction of oligodendrocyte processes (CNPase + filaments) and recruitment/activation of astrocytes ( Supplementary Fig. 8b ) and signs of necrosis (TNF-α and RIP1; Supplementary Fig. 8c ), all indicating neuroinflammation and neuronal damage.
Neural damage in the motor and somatosensor cortex-the regions compressed with our device-may consequently impair sensorimotor coordination and balance in mice, mimicking the neurological impairment that commonly occurs in brain tumour patients. By using Rotarod and static gait tests (Supplementary Video 6 and refs. 19, 20 ) , we found that motor coordination and locomotion was significantly reduced in mice where the cortex was compressed ( Fig. 5h,i 
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and Supplementary Fig. 8d ,e). The mice undergoing brain compression maintained normal body weight ( Supplementary Fig. 8f ). These findings mechanistically explain the results shown in patients and mice with nodular tumours ( Figs. 1 and 3 ) and the clinical evidence of the correlation of the mass effect events with performance in patients. The human brain has been shown to have a pronounced compression-tension asymmetry 21 and heterogeneity in its stiffness 22, 23 , as well as a broad spectrum of functions for each specific brain region. Consequently, we expect that the local compression of different areas of the brain might trigger different mechanical and neurological responses from the brain tissue. Therefore, further studies are needed to assess the regional effects of local solid stress from brain tumours.
In vivo removal of solid stress restores vascular perfusion and neurological function. Next, we asked whether the release of compression-simulating clinical surgical resection-leads to the rescue of the biological consequences of solid stress. First, we investigated Supplementary Fig. 8e . The data are the mean for three technical replicates and n mice per group ± s.e.m.
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NaTure BiOmedical eNgiNeeriNg a short-term decompression in brains compressed by a nodular tumour. After 20 days of nodular tumour growth in the brain of nude mice, we decompressed the brains by removing the cranial windows, mimicking craniotomy or surgical resection where consequent displacement has previously been shown 24, 25 . Thus, instead of a full surgical resection that would damage the surrounding tissue, this approach allowed us to partially release the tumour compressive forces and investigate intravital brain vessel perfusion. We observed a strong increase in perfusion in the surrounding brain after alleviation of the tumour-induced compressive forces ( Fig. 6a and Supplementary Fig. 9a -c).
Using the in vivo compression device in mice with no tumour, we next investigated whether the removal of solid stress-modelling a full tumour resection-leads to the restoration of vascular perfusion, neuronal damage and motor coordination ( Fig. 6b ). Removing solid stress after long-term compression-achieved by turning the screw backwards toward its original set-point-restored vascular perfusion ( Fig. 6c , Supplementary Fig. 9d and Supplementary Video 7). Histological analysis of cortices after 32 days of compression (longterm) showed massive brain tissue loss in the compressed area ( Fig. 6d ). Interestingly, two weeks after decompression, the brain showed a partial restoration of the micro-anatomy and number of neuronal cells (Fig. 6d,e and Supplementary Fig. 10a ). The release of the compression significantly improved motor coordination at two days after decompression ( Fig. 6f )-in line with previous data in post-surgery GBM patients 11 . However, motor coordination then dropped back again ( Supplementary Fig. 10b ), indicating an incomplete recovery.
These results allowed us to decouple the tumour mechanics from the biological interactions between the tumour and the surrounding normal tissue, thus mechanistically showing that both perfusion and neuronal function are impaired by solid stress and may be partially restored when the solid stress is removed, as occurs during surgical resection of the tumour 25 .
Systemic treatment with lithium protects neurons from solid stress-induced neuronal death and neurological dysfunction.
To reduce the compression-induced neuronal damage and further improve neurological ability, we tested potential neuroprotective therapeutic strategies aimed at preserving neuronal function in chronically compressed brain tissues. The compression device allowed us to screen multiple drugs in a single animal study. We systemically treated mice with the following drugs during the chronic/ gradual compression and the following two weeks after decompression ( Fig. 7a ): necrostatin-1 (7 mg kg −1 d −1 i.p.; similar to ref. 26 ), valproic acid (400 mg kg d −1 i.p. 27 ), lithium chloride (50 mg kg −1 d −1 i.p. 28 ) and dexamethasone (a single dose at maximum compression as shown in Supplementary Fig. 10d , 10 mg kg −1 i.p. 29, 30 ). These agents are known to cross the blood-brain barrier [31] [32] [33] , and have been shown to be neuroprotective during CNS ischaemia or Articles NaTure BiOmedical eNgiNeeriNg neurodegeneration [26] [27] [28] . No body weight loss was detectable in mice after one month of treatment ( Supplementary Fig. 10c ), indicating no evident toxicity of the drugs. Our results identified lithium as a potential neuroprotective agent, while necrostatin-1, valproic acid and dexamethasone showed no evident neuroprotective improvement in our experimental setting ( Supplementary Fig.  10c-e ). We replicated the compression/release experiment under lithium treatment (Fig. 7a ), and found that lithium significantly reduced neuronal death, and massively attenuated the reduction of cortical tissue area in the compressed brains ( Fig. 7b,c) . Moreover, ultrastructure analysis qualitatively showed reduced condensed chromatin (a sign of cell distress) in the lithium-treated cortices (Fig. 7d ). As a consequence, the Rotarod motor coordination in lithium-treated mice was improved during both the compression and decompression phases with 34% higher end-point endurance than in control mice ( Fig. 7e and Supplementary Fig. 10f ). Similar results were obtained with the static gait test ( Fig. 7f and Supplementary Fig. 10g) . 
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To gain mechanistic insight into the neuroprotective effect of lithium, we performed bulk RNA-sequencing (RNA-Seq) on cortices that were compressed, released and chronically treated with lithium or vehicle ( Fig. 7a ). With a sample size of 3 per group, a total of 21 genes were differentially expressed in lithium-treated cortices versus vehicle control ( Fig. 8a and Supplementary  Tables 1 and 2 ; false discovery rate (FDR) < 0.05). Of the 21 differentially expressed genes, 19 were upregulated and 2 were downregulated in the cortices of lithium-treated mice (Fig. 8a, Supplementary  Fig. 11a and Supplementary Tables 1 and 2 ). The function of these genes in the CNS were linked to ion channels, mitochondrial function and neuronal differentiation as well as protection from apoptosis, autophagy and ischaemia (Supplementary Tables 1  and 2 ). To systematically analyse our RNA-Seq results, we performed gene-annotation enrichment analysis using the DAVID Bioinformatics Resource 34 . Significantly upregulated gene ontologies in the lithium-treated group included dendrite, postsynaptic density, neuron projection (cellular components), protein binding (molecular function) and protein localization to synapse (biological process) ( Supplementary Fig. 11b-e 
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NaTure BiOmedical eNgiNeeriNg upregulated genes in the lithium-treated group (Supplementary Data 1b). Taken together, these results suggest that lithium treatment induces survival pathways in neurons (as demonstrated in Fig. 7b ,c) and point out how lithium preserves neuronal function during the compression/release phase. Finally, we tested whether lithium is neuroprotective if given when the compression and resulting neurological symptoms are already present in mice. Notably, in this more clinically relevant established compression model, lithium also efficiently increased the number of surviving neurons (Fig. 8b) .
These results show the therapeutic potential of lithium in preserving neuronal and neurologic function in CNS affected by brain tumour-generated solid stress.
Discussion
Brain tumours, particularly GBM and brain metastases, have poor prognosis and are associated with significant morbidity due to progressive neurologic dysfunction. Although huge efforts have been employed to inhibit or stop brain tumour growth, little is known about the reasons for neuronal loss in the surrounding brain tissue, which is the ultimate cause of significant neurological dysfunction, loss of quality of life and eventually death. One of the possible causes of neuronal loss is the tumour-generated solid stress exerted on the surrounding brain tissue. We previously predicted solid stress in and around non-CNS tumours 7 . However, the growth pattern of the tumour (infiltrative versus nodular), the actual mechanical properties of the tissues and the impact on the brain function were not experimentally investigated previously. We therefore decided to examine the effects of the growth pattern on the solid stress applied to the surrounding brain tissue. Our results showed higher solid stress in the tissue around nodular than infiltrative tumours and this prompted us to investigate whether this has consequences for neurological function. We found neuronal damage and reduced perfusion around nodular tumours with corresponding neurological dysfunction (Fig. 8c ). Importantly, these preclinical results allowed us to design a stratification method for GBM and BC patients with brain metastases using perfusion MRI, which can be used to predict which patients are likely to experience solid stress-mediated neurological impairment. We discovered an association between the growth pattern, reduced perfusion levels in the surrounding tissue and neurological impairment in a large set of patients across multiple cohorts. Notably, these associations were independent of peritumoural edema, widely recognized as an important determinant of neurological function in brain tumour patients, and treatment with steroids.
Using a custom-designed in vivo compression apparatus, we simulated the physical forces from nodular tumours exerted on the brain and we demonstrated a causal link between solid stress and a reversible reduction of vascular perfusion and semi-irreversible neurological dysfunction. Importantly, the neurons died as a consequence of the slow and chronic compression of the compression apparatus. This preclinical model allowed us to experimentally isolate the mechanical forces on the brain from other potential reasons of neuronal death and neurological dysfunction caused by brain tumours, such as excitotoxicity, inflammation, tumour release of neurotoxic factors and physical contact between tumour cells and normal brain. Moreover, we demonstrated that part of the dysfunction caused by the compression of the normal tissue could be rescued by the removal/release of solid stress, as happens during surgical resection, chemotherapy and radiotherapy. As removal is not sufficient to completely restore the cortex tissue and the neurological function (semi-irreversible effect), we therefore proposed the use of neuroprotective drugs to counter these effects.
Our results suggest lithium treatment as a potent neuroprotective therapeutic strategy in patients with nodular brain tumours, characterized by low perfusion in the surrounding tissue and lower KPS. For decades, lithium has been in use for psychiatric disorders, such as mania, depression and bipolar disorder. Notably, in our experiments the lithium dose administered here (50 mg kg −1 ) was comparable to or lower than that given to mice in anti-depressant experiments (50-400 mg kg −1 ; ref. 35 ). In preclinical models and clinical studies, lithium has been proved to have neuroprotective effects in several neurodegenerative, brain-injury and ischaemic models [36] [37] [38] [39] [40] [41] and this is in line with our RNA-Seq results. Notably, lithium also exerts anti-tumour effects by inhibiting tumour growth, chemosensitizing GBM preclinical models to temozolomide 42, 43 and reducing invasion of cultured GBM cells 44 , although its clinical efficacy remains to be determined in a clinical trial setting. These previous reports and our own findings support a potential therapeutic use of lithium in brain tumour patients.
Preservation of neurological function is increasingly taken into consideration in current clinical practice and neuro-oncologists now consider quality of life as a critical end point 45 . Our results now implicate solid stress as one of the causes of brain tumour-induced loss of neurological functions. Thus, our preclinical findings provide rigorous evidence for immediate translation of the concept of neuroprotection in the specific subclass of patients with nodular brain tumours who experience neurological defects due to the compression of the surrounding tissue. These agents can be used in addition to treatments that alleviate the tumour-generated mass effect to permit neuronal preservation while treatments to reduce tumour mass by surgery, radiation and chemotherapy are ongoing.
In conclusion, we showed that the compression-induced neuronal damage may be attenuated by decompression, mimicking surgical resection, and chronic systemic treatment with lithium ( Fig. 8d) .
These results indicate neuroprotective treatments as potential therapeutic strategies in patients with nodular 'pushing' tumours to reduce the pathological effects of solid stress on the surrounding brain neurons, even in cases of inoperable or advanced brain cancer to improve quality of life for as long as possible.
Methods
Mice. All animal protocols were approved by and in accordance with the guidelines established by the Institutional Animal Care and Use Committee (IACUC) at Massachusetts General Hospital (MGH). The mouse colony (MGH Cox7) was maintained in accordance with National Institutes of Health and MGH guidelines. MGH is accredited with the International Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and the NIH Office of Laboratory Animal Welfare (A3596-01). All experiments were performed in eightto ten-week-old female nude mice. In the case of Fig. 3a , we used CAG::H2B-EGFP (C57/BL6) mice from Jackson Laboratory.
Reagents and cell culture. Lithium chloride (L4408), valproic acid sodium salt (P4543) and necrostatin-1 (N9037) were from Sigma.
The human U87 and BT474 cells were from ATCC and the mouse Gl261 cells were from the National Cancer Institute Repository. MGG8, a cell line derived from a GBM patient, was previously established in the Department of Neurosurgery at MGH 46 . MGG8 and Gl261 cells were grown in serum-free conditions using the NeuroCult NS-A proliferation kit (Stemcell Technologies) [47] [48] [49] . Both cell lines were stably transduced with GFP or dsRed using a lentiviral construct. U87 cells were cultured in DMEM with 10% (vol/vol) FBS. Human HER2-amplified BC BT474 cells were cultured in RPMI 1640 supplemented with 10% FBS (Atlanta Biologicals) 50 . All cell lines were repeatedly tested and were negative for mycoplasma using the Mycoalert Plus Mycoplasma Detection Kit (Lonza) and were authenticated before use by IDEXX Laboratories (IDEXX, Human 9 and 16 species-specific STR marker profile).
Measurement of stress-induced deformation using the planar-cut method.
We slightly modified previous methods 4, 9 . The tissue deformation map was acquired via high-resolution ultrasound (Vevo 2100 system; FUJIFILM Visual Sonics) on the half of the tumour-brain that was immersed and relaxed in PBS. We used the probe MS550S for large samples (depth of view = 13 mm, frequency = 32-56 MHz) and the probe MS700 for smaller samples (depth of view = 9 mm, frequency = 30-70 MHz). The three-dimensional (3D) images were exported from VisualSonics software to MATLAB (The MathWorks) for postprocessing. The post-processing included smoothing, which was performed with moving averaging on the cut surface and bottom surfaces of the brain tumour to remove any noise introduced by ultrasound imaging. The top and bottom Articles NaTure BiOmedical eNgiNeeriNg surfaces were then exported to SolidWorks (Dassault System) to reconstruct a 3D object. This solid object was then exported to the compatible finite-element model ABAQUS (Dassault System), as described below.
Atomic force microscopy-based measurement of the indentation modulus (stiffness).
The indentation moduli of tumours and normal brain were quantified using an Asylum MFP3D atomic force microscope (AFM; Asylum). We used polystyrene colloidal probe tips with an end diameter of ~25 μ m (Polysciences) attached to tipless cantilevers with nominal spring constant k ≈ 0.12 N m −1 (Bruker). The colloidal probes were attached to the cantilever by the lift-off process: a dot of low-viscosity glue (M-Bond 610, Structure Probes/SPI Supplies) was placed on a tipless cantilever by making quick contact between the cantilever and a thin layer of glue (1 μ l thick) spread over a 10 × 10 mm mica surface. We then made immediate contact between the tip of the cantilever and a colloid probe resting on a glass slide and waited for 1 min with the cantilever pushing against the colloid. This process was followed by heat curing for 2 h at 150 °C. For each probe tip, the exact spring constants of the cantilevers were directly measured using the thermal calibration method. The relationship between the detected voltage and the applied force was calibrated by bringing the cantilever into contact with a glass slide and calculating the slope of the voltage-displacement curve. The displacement, d, was translated to force, F, using Hooke's law (F = kd; k is the cantilever spring constant). The indentation was performed under a force control scheme (maximum force ~20 nN) limiting the indentation depths to 0.5-3 μ m to stay in the linear regime. The tip displacement was obtained by subtracting the cantilever deflection from the vertical movement of the piezoelectric actuator. An indentation approach velocity of 2 μ m s −1 ensured that the elastic modulus was probed at rates lower than the characteristic frequency of tumour as a poroelastic tissue 51, 52 , to be close to equilibrium conditions. The effective indentation modulus E ind was computed using Hertzian contact mechanics models via least-squares linear regression of the experimental loading force-displacement curves. For the spherical colloidal probe tip with end radius R on the sample with thickness h » R (here, h ≈ 5 mm, R ≈ 12.5 μ m)
where F is the indentation force and D is the indentation depth (we assumed υ = 0.1, as measured in other soft tissues 53, 54 ). Despite differences in absolute values, the relative differences between the stiffness of brain parenchyma and tumour tissue are consistent with a previous publication where magnetic resonance elastography (MRE) has been utilized for stiffness measurement 55 . The discrepancies between our AFM measurement and MRE methods are potentially due to: the difference in the measurement methods (Young's modulus is estimated from the indentation modulus in the AFM measurement in quasi-equilibrium indentation, while the MRE is based on measurement of shear wave speed when the tissue is vibrated at a certain frequency, for example, 1,000 Hz 55 , which has a strong effect on the reported stiffness values 56 ); in vivo versus ex vivo settings (our AFM measurement is performed in vivo, while the MRE has been performed in vivo, when vascular and interstitial fluid pressures are present and may affect the stiffness values 57 ); and strain-stiffening effect (our measurements have been performed on stress-relaxed samples, while the stressed tissue may exhibit higher stiffness value due to material nonlinearity 58, 59 ).
Mathematical model.
By developing a mathematical model (2D axisymmetric finite-element model), the map of stress-induced deformation u i is converted to the strain tensor, ε = ∕ ∂ ∕∂ +∂ ∕∂ u x u x 1 2( ) ij i j j i , from which the stress tensor σ ij is estimated on the basis of Hooke's law, written in index notation as 60 :
where E is the modulus of elasticity (stiffness), ν is the Poisson ratio of the tissue based on linear isotropic assumption and δ ij is the Kroenecker delta. We chose a linear elastic model to reduce model parameters, and avoid associated assumptions. However, the mathematical model can be improved in multiple directions 1 : the use of hyperelastic models 61 to account for nonlinearity in the material properties of the normal brain tissue and brain tumours (for example, strain-stiffening 58, 59 in which stiffness values are altered in stressed tissues); the use of a poroelastic model 1 to account for the role of interstitial, vascular and cerebrospinal fluid pressure; and the use of a triphasic model to account for the electromechanics of brain and tumour tissue with fixed charge density 62 .
We developed our mathematical model using the general-purpose commercial finite-element software ABAQUS (Version 6.9, SIMULIA). The 3D geometry of the tumour is first smoothed to reduce any noise in MATLAB (MathWorks). Since the geometries of the tumours of interest are mainly spherical, we used an axisymmetric model ( Supplementary Fig. 1d ) to reduce the modelling and computational time. We used the eight-node axisymmetric element CAX8R for both the tumour and surrounding brain tissue with two elastic parameters: the Young modulus and the Poisson ratio, which are obtained as described above. We have previously shown that the solid stress relaxation time constant is on the order of 10 min or less 4 , following the linear poroelastic time constant predicted from the Young modulus and hydraulic permeability in poroelastic materials 51, 63 . Since the time constant of the biological processes that give rise to solid stress in tumours, such as proliferation, extracellular matrix deposition and cell contraction, ranges from several hours to days, much longer than the stress relaxation time constant, the equilibrium mechanical properties that we are measuring reflect the appropriate properties in the generation and application of solid stress.
Since the tumours of interest are all surrounded by the brain tissue, free of solid stress at locations far from the tumour, the cut surface in the brain provides the reference plane that represents the original plane of the tumour tissue before stress relaxation. A displacement profile is assigned to the top deformed surface of the tumour to translate it back to the original reference plane (Supplementary Video 1) . This assigned deformation is only in the direction perpendicular to the surface of the tumour (z direction), and the tumour top surface is free to move parallel to the surface direction (x-y plane). This displacement assignment translates the tumour geometry from the relaxed state (deformed surface) to the original stresses state before the cut (flat surface). The stress component σ zz that is generated after the displacement assignment is reported as the circumferential solid stress in the intact brain tumour. The boundary condition on the bottom surface of the surrounding brain tissue, far from the tumour, is defined as zero stress.
We are able to estimate the radial stress σ rr from σ zz , the stress component normal to the cut surface that is obtained from the planar-cut method if the following assumptions hold: the geometry and material properties of the tumour hold spherical symmetry around the centre of the tumour; the incision from the planar cut is going through the centre of the tumour (that is, σ zz is equivalent to σ θθ ); and the stress field goes to zero at the outer edges of the surrounding brain far from the tumour. With the above assumption, the following equation holds between σ rr and σ θθ = σ zz Having σ θθ = σ zz from the planar-cut method for the range of interest, and assuming σ rr = σ θθ = 0 at r = R 0 , the outer edge of the brain far from the tumour, the radial stress σ rr is estimated (Fig. 1a,b ).
Cranial window.
To implant transparent cranial windows, a 6-mm circle was drawn over the frontal and parietal regions of the skull bilaterally. Using a highspeed air-turbine drill with a burr-tip 0.5 mm in diameter, a groove was made on the margin of the drawn circle, until the bone flap became loose. The bone flap was separated from the dura mater underneath. The dura and arachnoid membranes were cut completely from the surface of both hemispheres, avoiding any damage to the sagittal sinus. The window was sealed with a 7-mm cover glass, glued to the bone with histocompatible cyanoacrylate glue.
Tumour implantation. To generate orthotopic tumours, ten days after the cranial window implantation the coverslip was removed and 1 μ l of 1-500,000 cells (MGG8, GL261, BT474) was stereotactically and slowly injected with a 28-gauge micro-syringe into the left striatum of 8-to 10-week-old female nude mice 2 mm left of the sagittal suture, 0.1 mm rostral of the bregma, and at a depth of 2 mm from the brain surface. In the case of U87 tumours, 1-mm chunks were implanted in the same region described above. Then a new cover glass was glued on. Of note, the brain tumour models we used are characterized by different degrees of infiltration in the surrounding tissue. Regarding the GBM models, U87 is the most nodular, GL261-although largely nodular-presents a low degree of infiltration and MGG8 is the most infiltrative. While U87 and MGG8 tumours rarely show necrosis when the tumours are not too large, GL261 tumours usually have multiple necrotic regions 48, 49 . BT474 tumours are mostly nodular and present necrosis when tumour volumes are large 50 .
Immunohistochemistry. Whole heads were collected after intracardiac perfusion with 2% formaldehyde in PBS and then fixed with 2% formaldehyde in PBS for 24-72 h. We next embedded the brains in paraffin, and 5-μ m-thick paraffin sections were cut using a microtome and mounted on glass slides. For IHC, tissues were deparaffinized, and antigen retrieval was performed in a pH 9 solution (DAKO) at 96 °C. To prevent nonspecific staining, sections were incubated with 5% normal donkey serum (Jackson ImmunoResearch) in PBS before incubation with the respective primary and secondary antibodies. The primary antibodies used are listed in Supplementary Table 3 .
Apoptag (ApopTag Peroxidase In Situ Apoptosis Detection Kit, no. S7100, Millipore) was used as a marker for apoptosis.
The number of neurons in the cortex was assessed by quantifying the number of NeuN + nuclei in mosaics of the coronal sections of the region of the cortex Articles NaTure BiOmedical eNgiNeeriNg exposed to the compression apparatus (that is, the anterior cingulate area, the primary and secondary motor area and the first part of the primary somatosensory area). The structures were identified using the mouse brain atlas map.
Intravital optical frequency domain imaging and perfused vessel analysis.
In vivo imaging of perfused vessels and analysis of the vascular fraction and diameter was performed using OCT as previously described 13, 64 . OCT assessment was performed at the indicated time until mouse death/euthanasia. The construction, design and algorithms used to derive and quantify OCT images were previously described in detail 13 . In Fig. 2a , we segmented and rendered vessels using a semi-automated algorithm (Bitplane Imaris Image Analysis software).
Multiphoton intravital microscopy.
For intravital microscopy, the cranial window-bearing animals were anaesthetized with isoflurane and fixed with a bilateral plastic holder. The multiphoton laser scanning microscope consisted of a MilleniaX pumped Tsunami Ti:sapphire laser (Spectra-Physics). The multiphoton laser scanning microscope consisted of an Olympus Fluoview FV300 system customized for multiphoton imaging. For carboxytetramethylrhodamine (TAMRA) and GFP 810-nm excitation laser light was used, while for EGFP/ DsRed/CasadeBlue sequential imaging with 730-and 930-nm excitation laser lights was used. Power at the sample was estimated to be 1-3 mW. The used emission band-pass filters were the following: 610 ± 75 nm for TAMRA/DsRed, 535 ± 43 nm for GFP/EGFP and 413 ± 4 nm for CascadeBlue. We performed vessel angiography after retro-orbital injection of 0.1 ml of 10 mg ml −1 TAMRA-or CascadeBlue-tagged dextran (500 kDa; in-house conjugated). The images shown are 3D renderings of high-resolution z stacks: 706 × 706 μ m (xy voxel of 0.69) and at least 50 μ m of z stack (z steps 2 μ m). We segmented and rendered vessels and tumour cells using a semi-automated algorithm (Bitplane Imaris Image Analysis software).
Ultrasound measurements of intracranial tumour volume.
To assess tumour size in U87 and BT474 preclinical models, in vivo imaging was performed through plastic cranial windows using a small animal ultrasonography device (Vevo 2100, FujiFilm VisualSonics Inc.).
In vivo lectin perfusion. For lectin perfusion analyses, mice were slowly (~2 min) injected with 100 ml of 1 mg ml −1 biotin-conjugated lectin (Vector Labs) via retro-orbital injection 5 min before brain collection, long enough for lectin to reach perfused vessels. Next, we performed 4% formaldehyde heart-perfusion. The brains were then excised, fixed in 4% formaldehyde in PBS overnight and embedded in paraffin blocks 4 .
Patient eligibility. Study A.
Sixty-four previously untreated ('pre-surgical') adult patients (mean age = 62 years; range 32-87; 29 females and 35 males) with a subsequent histologically confirmed diagnosis of a GBM were retrospectively recruited from a cohort of patients examined at our institution 65 . All patients were referred for a conventional MRI examination, including structural and contrast-enhanced perfusion imaging. Evidence of a contrast-enhancing tumour on structural MRI scans (> 1 cm in at least one dimension and/or > 10 cm 3 ) was required. No forms of anticancer medicines or Gliadel wafers were allowed for study inclusion, except for the use of steroids as part of standard-of-care. Other inclusion criteria included a KPS score of > 60. Use of steroids and KPS scores were recorded at the time of the MRI exam.
Study B.
A second cohort of 14 adult patients (mean age 59 years; range 35-77; 8 females and 6 males) with histologically confirmed newly diagnosed GBM ('postsurgical') at the time of the MRI exam was also retrospectively included 66 . The MRI exams were pulled from the baseline data (pre-therapy) part of an observational imaging study assessing the effects of chemo-radiation monotherapy (clinicalTrials. gov identifier NCT00756106). Except for the post-surgical status, the inclusion criteria matched those of the pre-surgical study described above. A minimum of > 1 cm residual tumour in at least one dimension was required and patients with gross total resections were excluded. Study C. Finally, baseline MRI data from a cohort of 34 patients (mean age 47 years; range 31-62; all females) with metastatic BC to the brain were pulled from an open-label, non-randomized, phase II study on carboplatin and bevacizumab (clinicalTrials.gov identifier NCT01004172). Patients were either HER2-negative (8 patients) or HER2-positive (26 patients). Evidence of a contrast-enhancing tumour on structural MRI scans (> 1 cm in at least one dimension) was required. Other inclusion criteria were no contraindication to MRI, an Eastern Cooperative Oncology Group performance status (ECOG PS) of 0-2, no increase in corticosteroid dose in the week before the baseline MR exam, left ventricular ejection fraction > 50%, and adequate bone marrow, liver and renal function. Patients could have received prior carboplatin monotherapy. Prior bevacizumab was allowed if it had not been given since or within 6 months before the diagnosis of CNS metastases. Prior radiation therapy to the brain was allowed, conditioned by radiologic confirmation of subsequent brain lesions progression, or presence of one or more untreated residual lesions for analysis in our study. Patients who had not received radiotherapy were allowed if they did not require corticosteroids.
There was no limit on the number of prior therapies. A two-week washout period was required from chemotherapy or any other investigational therapy. A one-week washout period was required for lapatinib. No washout period was required for trastuzumab.
All patient studies were approved by the Institutional Review Boards of MGH or Dana-Farber, including the use of informed consent.
MRI acquisition.
For all studies, each subject was scanned before the start of therapy. For study A 65 , patients were scanned on either a 1.5 Tesla MRI system (Signa; GE Healthcare) or a 3.0 Tesla MRI system (TimTrio, Siemens Healthcare). For studies B and C, all MRI exams were performed at 3.0 Tesla (TimTrio, Siemens Healthcare) 66 . The MRI scans specific for our study were typically as follows.
T2-weighted images. Axial T2-weighted images images with a repetition time (TR) of 4,000 milliseconds (ms), echo time (TE) 104 ms, 5 millimeters (mm) slice thickness, 1 mm inter-slice gap, 0.43 mm in-plane resolution, 19-23 slices and a 512 × 512 image voxel matrix. Axial fluid-attenuated inversion recovery (FLAIR) images with TR 10,000 ms, TE 70 ms, inversion time (TI) 1,500 ms, 5 mm slice thickness, 1 mm inter-slice gap, 0.43 mm in-plane resolution, 23-25 slices and a 512 × 512 image voxel matrix.
T1-weighted images. Axial T1-weighted images acquired before-and after (CE-T1)-injection of contrast agent (gadopentetate-dimeglumine, Gd-DTPA, Magnevist, Bayer Schering Pharma AG). TR 600 ms, TE 12 ms, 5 mm slice thickness, 1 mm inter-slice gap, 0.43 mm in-plane resolution, 23 slices and a 512 × 512 image voxel matrix.
Diffusion images. Axial images using a twice refocused echo-planar diffusionweighted sequence with TR ~8,000 ms, TE 80-85 ms, low and high b values of 0 s mm −2 and 700 s mm −2 in 7 and 42 directions, respectively, for diffusion tensor reconstruction. The resolution was 2 mm isotropic, 64 slices and a 128 × 128 image voxel matrix.
Perfusion images. Axial dynamic susceptibility contrast (DSC) images using a gradient-echo echo-planar imaging sequence with TR 1,400-1,500 ms, TE 30-35 ms, flip angle 90°, 5 mm slice thickness, 1.5 mm inter-slice gap, 1.2 mm in-plane resolution, 12 slices and a 160 × 160 image voxel matrix. A total of 100 volumes were acquired and 0.1 mmol kg −1 of Gd-DTPA was injected at 5 cm 3 s −1 after approximately 81 s of imaging. In addition, for studies B and C as part of a dynamic contrast enhanced image acquisition preceding the dynamic susceptibility contrast imaging, patients also received 0.1 mmol kg −1 of Gd-DTPA acting as a pre-dose to minimize computational errors due to T 1 -shortening effects induced by contrast agent leakage in regions of blood-brain barrier breakdown or resection.
MRI post-processing. Volumetrics. Using a previously described volumetric approach 67 , areas of signal intensity abnormality on T2-weighted, FLAIR and CE-T1 images were outlined by an experienced neuroradiologist blinded to the order of the scans. Total tumour volume was estimated by summing all voxels in the enhancing tumour. All images, including the tumour outlines from the second visit, were realigned to the perfusion MR images at the first visit using normalized mutual information coregistration in Matlab (MathWorks).
Diffusion. Apparent diffusion coefficient maps estimating the relative water selfdiffusion on a voxel-by-voxel basis were created from the low-and high-b-value images using standard Steskjal-Tanner diffusion approximation 68 as well as measures of fractional anisotropy 69 .
Perfusion. Cerebral blood flow maps from the gradient-echo perfusion MRIs were calculated using established models in nordicICE (NordicNeuroLab) and corrected for contrast-agent leakage 70 . Patient-specific variations were reduced by normalization of all brain voxel values to an average value from a normalappearing grey-and white-matter tissue map excluding pathological areas as identified by the neuroradiologist on the MRIs 71 .
Perfusion-gradient analysis. An image voxel-level, unsupervised morphological dilatation in Matlab was performed from the edge of the pathologic area (CE-T1, T2-weighted and FLAIR) and in steps equalling one image voxel growth in all outwards directions ( Supplementary Fig. 5a ). The algorithm was allowed to grow only in regions with voxels included in the normal-appearing grey-and whitematter tissue map, excluding large vessels, regions of necrosis and/or cysts 71, 72 . A stable/increase ('unchanged perf ') or reduction ('reduced perf ') in the perfusion gradient in the peri-edematous region was defined as being over/below a 5% difference from the average perfusion value of normal-appearing tissue in regions outside a > 10 pixel range (> 12 mm distance from the peri-edematous zone).
VASARI scoring of MRI. Pre-surgical MRI images for the 64 treatment-naive GBM (Study A) were qualitatively scored for morphological features associated with nodular and infiltrative phenotypes by a board-certified neuroradiologist reader with 10 years of clinical and research experience on brain tumours. The reader was blinded to clinical information (KPS, overall survival) and advanced Articles NaTure BiOmedical eNgiNeeriNg MRI data (perfusion metrics) and classified tumours as 'well defined' versus 'poorly defined' according to features f12 and f13 of the VASARI criteria 8 (https://wiki.cancerimagingarchive.net/display/Public/VASARI+ Research+ Project) utilizing CE-T1, T2-weighted and FLAIR images, respectively. In addition, tumours were scored according to their shape on CE-T1, T2-weighted and FLAIR images utilizing an ordinal four-tier scheme: sphere/oval; sphere/oval + lobulations; irregular; and non-mass or diffuse/patchy. Nodular, well-defined tumours usually grow concentrically and are expected to have more spherical/oval shapes, while infiltrative, poorly marginated tumours are expected to have more irregular or diffuse/patchy appearances.
Compression apparatus model. The compression apparatus is comprised of a polyvinyl chloride (PVC) circular disc (2 mm thick, 7 mm in diameter) acting as a modified cranial window, a stainless-steel set screw (M2x5mm) to apply the controlled chronic displacement on the brain tissue, a PVC membrane (0.01 mm thick) to separate the brain tissue from the set screw and other components, and a custom-made polydimethylsiloxane disc (1 mm thick, 3 mm in diameter) that surrounds the set screw from the top of the window to reduce potential backlash, backing off or loosening of the set screw. All of the components are purchased from McMaster-Carr. The PVC membrane is attached to the edge of the PVC disc by glue. The outer side of the PVC membrane, which is in contact with brain tissue, is clear of any glue to avoid any toxicity. The device is rinsed with ethanol before the surgical procedure.
The compression was performed under gas anaesthesia (isoflurane) every 2-3 days. Each turn of the screw was measured by OCT to be sure that an equal amount of compressing volume was applied to every cortex. No tissue toxicity was detected in brain in contact with the membrane of the compression apparatus. No haemorrhages occurred in any mouse as a consequence of compression or decompression of the cortex. In rare cases of rupture of the membrane of the compression apparatus, the apparatus inevitably fell off the implantation causing a change in intracranial pressure; in those cases, we immediately euthanized and excluded the mice from the study. Mice were checked daily for potential pain and distress. At the end point, each compression apparatus was checked to confirm that no breach of the membrane had occurred.
Histology. Whole heads were collected after intracardiac perfusion with 2% formaldehyde in PBS and then fixed with 2% formaldehyde in PBS for 24-72 h. We next embedded the brains in paraffin, and 5-μ m-thick paraffin sections were cut using a microtome and mounted on glass slides. Haematoxylin-eosin (H&E) and cresyl violet (Nissl staining) stains are commonly used histological methods for morphological assessments of the cells in brain tissue. Thus, the paraffin slices were stained with H&E and cresyl violet in the study for histologic evaluation.
Ultrastructural analysis by electron microscopy. Whole heads were collected after intracardiac perfusion with 2% formaldehyde and 2% glutaraldehyde in PBS and then fixed with 2% formaldehyde and 2% glutaraldehyde in PBS for 24-72 h. Vibratome sections (50 μ m) of mouse brain were post-fixed in 2.5% glutaraldehyde/PBS for 30 min, washed well in PBS, and treated with 1% osmium tetraoxide/PBS for 1 h, then 1% uranyl acetate/70% ethanol for 45 min. The tissue was then dehydrated in alcohol, embedded in EPON, thin-sectioned on an UltraCut E (Reichert-Jung), and examined using a JEOL JEM-1011 transmission electron microscope with AMTv601 software (Advanced Microscopy Techniques).
RNA isolation and quantitative real-time PCR. Mouse brain tissues were homogenized and total RNA was isolated utilizing the RNeasy Mini kit (Qiagen) according to the manufacturer's protocol. Genomic DNA was removed using the RNase-Free DNase Set (Qiagen). One microgram of RNA was used for the firststrand cDNA synthesis (Bio-Rad). A no-reverse transcriptase control was included in the same PCR mixtures without reverse transcriptase to confirm the absence of DNA contamination in RNA samples. Quantitative real-time PCR (qPCR) primers were synthesized at the MGH DNA core facility ( Supplementary Table 4 ). Reactions (25 μ l) were carried out in 96-well optical reaction plates using SYBR Green PCR Master Mix (Bio-Rad) with gene-specific primers, and the qPCR was run in the Stratagene Mx3000p Real-Time PCR System. Amplification of each sample was analysed by melting curve analysis, and relative differences in each PCR sample were corrected using GAPDH messenger RNA as an endogenous control and normalized to the level of the control by using the 2 −ΔΔCt method as previously described 73, 74 .
Rotarod test. The neurological function of the mice was assessed by using an automated Rotarod (Rotamex 4/8 4-Lane Treadmill Shock Grid; Columbus Instruments). To exclude the effect of motivational factors and to differentiate between motor learning and actual neurological function, mice were trained on the Rotarod every day for three days. Mice were randomized at the beginning of the study to have the same means in Rotarod endurance. The Rotarod test was performed always at a similar period of the day and after 1 h of acclimation of the mice in the room. We excluded mice that repeatedly fell off very early (< 20 s). Tests in two consecutive days were performed for each animal. Each test began with a 30 s acclimation period at 4 r.p.m. followed by acceleration by 4 r.p.m. every 30 s. The latency to fall was recorded as Rotarod endurance 75 .
Static gait test. Gait characteristics (stride and track length) were analysed by applying ink to the animals' hind paws and letting them walk on a strip of paper, inside a brightly lit alley (4.5 cm large, 40 cm long), towards a dark goal box. Mice were tested three consecutive times on the day of maximum compression of the cortex (day 12).
Short-term release of the solid stress. The release of the tumour-induced compression of the surrounding tissue was performed by removing the cranial window from anaesthetized mice. This allowed us to obtain a map of the mechanical stress-induced deformation in a brain with or without the nodular U87 tumour. We then checked the dynamics of in vivo perfusion during the process of the release of the tumour-induced compression by OCT. Mice were then euthanized.
Therapeutic neuroprotection treatments. Mice were randomized at the beginning of the study by Rotarod endurance. We systemically treated mice with the following drugs during the chronic/gradual compression and the two following weeks after decompression: necrostatin-1 (7 mg kg −1 d −1 i.p.; similar to ref. 26 ), valproic acid (400 mg kg −1 d −1 i.p. 27 ) and lithium chloride (50 mg kg −1 d −1 i.p. 28 ). All of these drugs are known to cross the blood-brain barrier [31] [32] [33] and shown to be neuroprotective during CNS ischaemia or neurodegeneration [26] [27] [28] . In the case of dexamethasone, the steroid anti-edema drug was given once (10 mg kg −1 ; refs. 29, 30 ) at the day of maximum compression (day 14). In the case of lithium treatment 'intervention study' (that is, with treatment start when compression was already applied to the brains), lithium chloride (50 mg kg −1 d −1 i.p. 28 ) was given from day 10 after the chronic compression initiation.
RNA-Seq. RNA-Seq was performed by the Massachusetts Institute of Technology BioMicro Center. The quality of RNA samples was confirmed using a fragment analyser (Advanced Analytical Technologies, Inc.) before Illumina libraries were prepared and indexed from ~250 ng of total RNA using the Kapa Hyperprep kit following the manufacturer's recommendations (Roche). Libraries were confirmed using the fragment analyser and quantified by qPCR before pooling and sequencing on an Illumina NextSeq500 using 40 + 40 paired end reads. Samples were demultiplexed using custom scripts allowing a single mismatch to the index sequencing.
Analysis of RNA-Seq data. The raw FASTQ files were aligned by STAR 76 to the Ensembl GRCm38 reference genome. Gene read counts were then generated using the Bioconductor R package GenomicAlignments 77 . The Bioconductor R package DESeq2 78 was then used to normalize and determine the differentially expressed genes. The DAVID Bioinformatics Resource 34 was used for gene-annotation enrichment analysis on the differentially expressed genes.
Statistical analysis. Unless otherwise specified, the data are presented as the mean ± s.e.m. Student's two-tailed t-tests based on Gaussian distributions were used to assess the significance. For comparisons among more than two groups, analysis of variance or Kruskal-Wallis tests were followed by post hoc multiple comparisons. P < 0.05 was considered significant. For comparison between categorical datasets, Fisher's test was performed. Blinding during analysis was used for all of the experiments and clinical analyses. Statistics were performed using Graphpad Prism or Microsoft Excel. A detailed list of the performed tests is provided in Supplementary Table 5 .
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Code availability. The computer codes used in this study are available from the corresponding author upon reasonable request.
Data availability
The authors declare that all data supporting the findings of this study are available within the paper and its Supplementary Information. Raw RNA-Seq data from this study have been deposited in the NCBI Sequence Read Archive (SRA) under submission ID SUB4405185 and BioProject ID PRJNA486395.
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Data collection
Images were collected with imaging software, such as Zen lite for IHC, Vevo VisualSonics for ultrasound, Olympus FluoView for confocal and multi-photon, AMTv601 software for TEM, nordicICE v3 for MRI and a custom-made software for OCT (as previously described in Vakoc, Nat Med, 2009 ).
Data analysis
The following commercial software were used to analyze the results: VisualSonics software, SolidWorks, ABAQUS Version 6.9, Bitplane Imaris 7.0 Image Analysis software, Graphpad Prism 7, Microsoft Excel and ImageJ. Moreover, we used previously published MATLAB and ImageJ custom algorithms.
The computer codes are available from the corresponding author upon reasonable request.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
